Worldwide Rates and Determinants of Depression and Anxiety Among Individuals with Liver Cirrhosis: A Systematic Review and Meta-Analysis - Report - MDSpire

Worldwide Rates and Determinants of Depression and Anxiety Among Individuals with Liver Cirrhosis: A Systematic Review and Meta-Analysis

  • By

  • Omar Abureesh

  • Araek Al-Shraideh

  • Joelle Sleiman

  • Chloe Lahoud

  • Brendan Plann-Curley

  • Liliane Deeb

  • April 17, 2026

  • 0 min

Share

Clinical Report: Worldwide Rates and Determinants of Depression and Anxiety in Cirrhosis

Overview

This systematic review and meta-analysis reveal a pooled prevalence of 37% for depression and 53% for anxiety among patients with liver cirrhosis. Key demographic and etiological factors, such as age and alcoholism, are associated with increased incidence of these mental health disorders.

Background

Liver cirrhosis affects approximately 122 million individuals globally and is associated with significant morbidity and mortality. The psychological burden of depression and anxiety in these patients can impair treatment adherence and overall quality of life. Understanding the prevalence and determinants of these mental health issues is crucial for improving patient outcomes.

Data Highlights

ConditionPooled Prevalence95% Confidence Interval
Depression0.370.29–0.46
Anxiety0.530.33–0.73

Key Findings

  • The pooled prevalence of depression in cirrhotic patients is 37%.
  • The pooled prevalence of anxiety in cirrhotic patients is 53%.
  • Age, alcoholism, and viral etiologies are linked to increased depression incidence.
  • Advancing age correlates with higher depression prevalence (p = 0.02).
  • High heterogeneity was noted in the prevalence estimates across studies.

Clinical Implications

Routine screening for depression and anxiety in patients with liver cirrhosis is essential to enhance their quality of life and treatment adherence. Clinicians should consider demographic and etiological factors when assessing mental health in these patients.

Conclusion

The high prevalence of depression and anxiety among patients with liver cirrhosis underscores the need for standardized mental health assessments in clinical practice to improve patient outcomes.

References

  1. Author(s)/Org, Source, Year -- Title
  2. BMC Psychiatry (Springer) -- Exploring Sexual Health, Anxiety, and Depression in Candidates and Recipients of Liver Transplants in Iran
  3. BMC Psychiatry (Springer) -- The efficacy of probiotics, prebiotics, and synbiotics on anxiety, depression, and sleep: a systematic review and meta-analysis of randomized controlled trials
  4. BMC Psychiatry (Springer) -- Association between anxiety disorders and medication adherence in patients with cardiovascular disease: a systematic review and meta-analysis of observational studies
  5. Official journal of the American College of Gastroenterology | ACG
  6. Palliative Care and Symptom-Based Management in Decompensated Cirrhosis | AASLD
  7. Hepatology
  8. Official journal of the American College of Gastroenterology | ACG
  9. Palliative Care and Symptom-Based Management in Decompensated Cirrhosis | AASLD
  10. Hepatology

Original Source(s)

Related Content